X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Consumer with GOODRICKE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs GOODRICKE - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

GOODRICKE 
   Change

Goodricke Group was incorporated in West Bengal in 1977 as a Public Limited Company under the provisions of the Companies Act 1956 (Act). The company grows, cultivates, manufactures, treats, blends, processes, buys, sells and deals in tea in various ... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER GOODRICKE GSK CONSUMER/
GOODRICKE
 
P/E (TTM) x 34.1 16.2 210.2% View Chart
P/BV x 9.2 2.8 323.3% View Chart
Dividend Yield % 1.3 1.6 81.8%  

Financials

 GSK CONSUMER   GOODRICKE
EQUITY SHARE DATA
    GSK CONSUMER
Mar-16
GOODRICKE
Mar-16
GSK CONSUMER/
GOODRICKE
5-Yr Chart
Click to enlarge
High Rs6,771220 3,080.4%   
Low Rs5,448127 4,289.8%   
Sales per share (Unadj.) Rs1,024.4344.6 297.3%  
Earnings per share (Unadj.) Rs163.3-6.0 -2,738.9%  
Cash flow per share (Unadj.) Rs177.02.4 7,253.7%  
Dividends per share (Unadj.) Rs70.004.00 1,750.0%  
Dividend yield (eoy) %1.12.3 49.7%  
Book value per share (Unadj.) Rs581.587.9 661.6%  
Shares outstanding (eoy) m42.0621.60 194.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.00.5 1,185.0%   
Avg P/E ratio x37.4-29.1 -128.6%  
P/CF ratio (eoy) x34.571.1 48.6%  
Price / Book Value ratio x10.52.0 532.6%  
Dividend payout %42.9-67.1 -63.9%   
Avg Mkt Cap Rs m256,9593,745 6,860.6%   
No. of employees `0003.724.5 15.2%   
Total wages/salary Rs m5,0942,752 185.1%   
Avg. sales/employee Rs Th11,548.5303.9 3,800.3%   
Avg. wages/employee Rs Th1,365.3112.3 1,215.3%   
Avg. net profit/employee Rs Th1,841.1-5.3 -35,008.3%   
INCOME DATA
Net Sales Rs m43,0877,442 579.0%  
Other income Rs m2,788118 2,356.3%   
Total revenues Rs m45,8757,561 606.8%   
Gross profit Rs m8,349-244 -3,420.2%  
Depreciation Rs m574182 316.5%   
Interest Rs m826 30.3%   
Profit before tax Rs m10,554-333 -3,165.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0370 0.0%   
Tax Rs m3,685166 2,222.4%   
Profit after tax Rs m6,869-129 -5,333.2%  
Gross profit margin %19.4-3.3 -590.8%  
Effective tax rate %34.9-49.7 -70.2%   
Net profit margin %15.9-1.7 -921.2%  
BALANCE SHEET DATA
Current assets Rs m37,5602,016 1,863.0%   
Current liabilities Rs m18,1531,440 1,260.8%   
Net working cap to sales %45.07.7 581.7%  
Current ratio x2.11.4 147.8%  
Inventory Days Days3967 58.3%  
Debtors Days Days3018 171.3%  
Net fixed assets Rs m5,3741,388 387.3%   
Share capital Rs m421216 194.7%   
"Free" reserves Rs m24,0031,667 1,439.9%   
Net worth Rs m24,4561,899 1,288.2%   
Long term debt Rs m00-   
Total assets Rs m44,9883,542 1,270.2%  
Interest coverage x1,336.9-11.8 -11,355.2%   
Debt to equity ratio x00-  
Sales to assets ratio x1.02.1 45.6%   
Return on assets %15.3-2.9 -527.2%  
Return on equity %28.1-6.8 -414.0%  
Return on capital %43.23.3 1,299.4%  
Exports to sales %5.113.4 38.2%   
Imports to sales %0.40.6 62.2%   
Exports (fob) Rs m2,2111,000 221.0%   
Imports (cif) Rs m16847 359.9%   
Fx inflow Rs m2,8161,000 281.5%   
Fx outflow Rs m26159 443.8%   
Net fx Rs m2,555942 271.4%   
CASH FLOW
From Operations Rs m5,724472 1,212.6%  
From Investments Rs m-1,569-174 902.1%  
From Financial Activity Rs m-2,792-223 1,254.8%  
Net Cashflow Rs m1,36376 1,802.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 72.5 74.0 98.0%  
Indian inst/Mut Fund % 0.8 0.0 2,666.7%  
FIIs % 12.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 26.0 56.9%  
Shareholders   26,457 13,943 189.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   VENKYS (I) LIMITED  MCLEOD RUSSEL  RASOYA PROTEINS  ZYDUS WELLNESS  UNITED BREWERIES  

Compare GSK CONSUMER With:   COCA COLA (US)  NESTLE (Switz.)  TIGER BRANDS (S. Africa)  AVI LTD. (S. Africa)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

GSK Consumer: Price Hike Hurts Volumes (Quarterly Results Update - Detailed)

Nov 30, 2016

GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.

ITC: Demonetisation woes pull down business growth (Quarterly Results Update - Detailed)

Feb 8, 2017

ITC Ltd has announced third quarter results of the financial year 2016-2017 (3QFY17). The company has reported 4.7% YoY and 5.7% YoY growth in revenues and net profits respectively. Here is our analysis of the results.

ITC: A Decent Quarter Amidst Challenging Environment (Quarterly Results Update - Detailed)

Dec 7, 2016

ITC has announced second quarter results of the financial year 2016-2017 (2QFY17). The company has reported 8% YoY and 10.5% YoY growth in revenues and net profits respectively.

GSK Consumer: Slowdown in demand impacts sales (Quarterly Results Update - Detailed)

Oct 5, 2016

GSK Consumer Healthcare has announced the first quarter results of the financial year 2016-2017 (1QFY17). The company's sales declined by 1.4% YoY while net profit rose by 2.9% YoY during the quarter.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Aug 21, 2017 01:58 PM

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 5-YR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS